Ping An Ventures Takes Equity Stake in 20/20 GeneSystems

Investment to Accelerate Commercialization of Lung Cancer Test in China The funds will support 20/20’s efforts to customize for the Chinese market its proprietary algorithm for blood biomarker testing for cancer. The algorithm will then be made available to...